Calls
1
u/itstonymontana
Reddit r/wallstreetbets
Win Rate
100.0%
return
+89.0%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 12
$34.25
+89.0%
The author is bullish on Travere Therapeutics ahead of the FDA's decision on Filspari for FSGS. The bull case rests on the DUPLEX trial's significant proteinuria reduction, which the FDA co-authored PARASOL paper identifies as a valid surrogate endpoint, and the lack of approved treatments may enable accelerated approval. The main stated risk is that the FDA may require complete remission rather than partial, and it previously stated the DUPLEX data were not sufficient for a supplemental NDA.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/itstonymontana has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: TVTX.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
